CNSX:BIO Bio-Rad Laboratories (BIO) Stock Price, News & Analysis Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolume265,600 shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Bio-Rad Laboratories alerts: Email Address Ad Porter & CompanyThe death of Nvidia?Today, I’m warning of another looming catastrophe. Only this time, it’s not in pot stocks, cryptos, or U.S. housing… it's in artificial intelligence. And unless you know what’s really going on in this sector, you could be wiped out. You see, while there is no doubt that the recent advancements in artificial intelligence are game-changing and will drive colossal innovation in every sector of the economy... There's also no escaping that The Big AI Die-Up is coming.So go here now to read my new report The Big AI Die-Up… while you still can. About Bio-Rad Laboratories Stock (CNSX:BIO)Biome Grow Inc. focuses on the cannabis business. Biome Grow Inc. is headquartered in Toronto, Canada.Read More Ad Porter & CompanyThe death of Nvidia?Today, I’m warning of another looming catastrophe. Only this time, it’s not in pot stocks, cryptos, or U.S. housing… it's in artificial intelligence. And unless you know what’s really going on in this sector, you could be wiped out. You see, while there is no doubt that the recent advancements in artificial intelligence are game-changing and will drive colossal innovation in every sector of the economy... There's also no escaping that The Big AI Die-Up is coming.So go here now to read my new report The Big AI Die-Up… while you still can. BIO Stock News HeadlinesSeptember 5 at 9:49 AM | nz.finance.yahoo.comBiodesix to Present at Two Investor Conferences in SeptemberAugust 22, 2024 | finance.yahoo.comBio-Rad’s Management to Participate in Fireside Chat During Wells Fargo’s 2024 Healthcare ConferenceSeptember 7, 2024 | Timothy Sykes (Ad)Tim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT about Trump or Biden dropping out of the race…August 17, 2024 | msn.comJimmy Kimmel’s Kimmalot Banner Exits Out of Brent Montgomery’s WheelhouseAugust 13, 2024 | finance.yahoo.comDrug Abuse Testing Market Report By Drug Type, Product & Services, Sample Type, End Users Countries and Company Analysis - Global Forecast to 2032August 9, 2024 | msn.comBio-Rad Launches Annexin V StarBright Conjugates for Apoptosis Detection via Flow CytometryAugust 6, 2024 | msn.comBio-Rad Laboratories, Inc. (BIO): Should You Invest In This Organ Transplant and Diagnosis Stock Right Now?August 5, 2024 | ca.finance.yahoo.comBIO Aug 2024 240.000 callSeptember 7, 2024 | Timothy Sykes (Ad)Tim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT about Trump or Biden dropping out of the race…August 2, 2024 | markets.businessinsider.comHold Rating Maintained for Bio-Rad Laboratories Amid Mixed Performance and Market HeadwindsAugust 2, 2024 | ca.finance.yahoo.comBIO Sep 2024 350.000 callAugust 1, 2024 | finance.yahoo.comBio-Rad Reports Second-Quarter 2024 Financial ResultsAugust 1, 2024 | seekingalpha.comBio-Rad Laboratories, Inc. (BIO) Q2 2024 Earnings Call TranscriptJuly 31, 2024 | markets.businessinsider.comHere's what Wall Street expects from Bio-Rad Laboratories's earnings reportJuly 29, 2024 | finance.yahoo.comRapid Microbiology Testing Market Valuation Poised to Reach USD 9,716.1 Million By 2032 | Astute AnalyticaJuly 26, 2024 | msn.comBio-Rad Laboratories’ (BIO) Growth Tailwinds Are Delayed, Not DerailedJuly 24, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: HCA Healthcare (HCA) and Danaher (DHR)May 23, 2024 | finance.yahoo.comBio-Rad’s Management to Participate in Fireside Chat During Jefferies Global Healthcare ConferenceSee More Headlines Receive BIO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Bio-Rad Laboratories and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeCNSX SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolCNSX:BIO CUSIPN/A CIKN/A Webwww.biomegrow.com Phone416-875-8395FaxN/AEmployees8,000Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Ten Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free Report Key ExecutivesMr. Khurram Malik MBACEO, President & DirectorMr. Abbey Abdiye C.M.A. (Age 49)CPA, Chief Financial Officer Comp: $110.95kScott CuthbertsonVP of Investor RelationsMr. Frank MacMasterPresident of Highland Grow Inc.David CallahanPresident of The Back Home Medical Cannabis CorporationKey CompetitorsAbattis BioceuticalsCNSX:ATTAgraflora Organics InternationalCNSX:AGRAAmplify Alternative Harvest ETFCNSX:MJBlueberries MedicalCNSX:BBMBooksAMillionCNSX:BAMMView All Competitors BIO Stock Analysis - Frequently Asked Questions How do I buy shares of Bio-Rad Laboratories? Shares of BIO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Bio-Rad Laboratories own? Based on aggregate information from My MarketBeat watchlists, some other companies that Bio-Rad Laboratories investors own include Cross Timbers Royalty Trust (CRT), InfraCap MLP ETF (AMZA), Alliance Resource Partners (ARLP) and Curaleaf (CURLF). This page (CNSX:BIO) was last updated on 9/7/2024 by MarketBeat.com Staff From Our PartnersPerfect Crypto Buying Opportunity for 50 CentsWhen cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying wit...Crypto 101 Media | SponsoredThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial inde...Golden Crest | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredMy grim warning about AI stocksToday, I’m warning of another looming catastrophe. Only this time, it’s not in pot stocks, cryptos, or U.S....Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bio-Rad Laboratories, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bio-Rad Laboratories With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.